Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP499512.RAVux-TWbMbZU5b3R0mViwBlcirnV605GHDemKBgVs8go130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP499512.RAVux-TWbMbZU5b3R0mViwBlcirnV605GHDemKBgVs8go130_assertion type Assertion NP499512.RAVux-TWbMbZU5b3R0mViwBlcirnV605GHDemKBgVs8go130_head.
- NP499512.RAVux-TWbMbZU5b3R0mViwBlcirnV605GHDemKBgVs8go130_assertion description "[Furthermore, leukemic cells from infants with MLL were significantly more sensitive to the Fms-like tyrosine kinase 3 (FLT3) inhibitor PKC412 (N-benzoyl staurosporine) than noninfant ALL cells, and at least as sensitive as internal tandem duplication-positive (ITD+) AML cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499512.RAVux-TWbMbZU5b3R0mViwBlcirnV605GHDemKBgVs8go130_provenance.
- NP499512.RAVux-TWbMbZU5b3R0mViwBlcirnV605GHDemKBgVs8go130_assertion evidence source_evidence_literature NP499512.RAVux-TWbMbZU5b3R0mViwBlcirnV605GHDemKBgVs8go130_provenance.
- NP499512.RAVux-TWbMbZU5b3R0mViwBlcirnV605GHDemKBgVs8go130_assertion SIO_000772 15956279 NP499512.RAVux-TWbMbZU5b3R0mViwBlcirnV605GHDemKBgVs8go130_provenance.
- NP499512.RAVux-TWbMbZU5b3R0mViwBlcirnV605GHDemKBgVs8go130_assertion wasDerivedFrom befree-2016 NP499512.RAVux-TWbMbZU5b3R0mViwBlcirnV605GHDemKBgVs8go130_provenance.
- NP499512.RAVux-TWbMbZU5b3R0mViwBlcirnV605GHDemKBgVs8go130_assertion wasGeneratedBy ECO_0000203 NP499512.RAVux-TWbMbZU5b3R0mViwBlcirnV605GHDemKBgVs8go130_provenance.